SRPTWM
ELDN icon

Split Rock Private Trading & Wealth Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Split Rock Private Trading & Wealth Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4K Hold
10,000
– – 0.03% 49
2026
Q1 		$30.8K Hold
10,000
– – 0.02% 46
2025
Q4 		$15.1K Buy
+10,000
New +$23.8K 0.01% 36

Other funds holding ELDN

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PNFS
PW Nova Financial Services Newtown, Pennsylvania $466M AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Split Rock Private Trading & Wealth Management's ELDN Position: Q2 2026 in Review

Split Rock Private Trading & Wealth Management held its Eledon Pharmaceuticals (ELDN) position steady in Q2 2026 at 10,000 shares worth $39.4K. The position accounts for 0.03% of the portfolio, ranked #49.

Split Rock Private Trading & Wealth Management first reported a position in ELDN in Q4 2025 and has held it in 3 quarters since. 57 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Split Rock Private Trading & Wealth Management held 10,000 shares of Eledon Pharmaceuticals worth $39.4K as of Q2 2026.
  • Split Rock Private Trading & Wealth Management left its Eledon Pharmaceuticals share count unchanged in Q2 2026.
  • Eledon Pharmaceuticals made up 0.03% of Split Rock Private Trading & Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Split Rock Private Trading & Wealth Management first reported a position in Eledon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 57 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Split Rock Private Trading & Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.